34D.F 101.75 (+1.24%)
IT0003492391• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. 34D.F

Diasorin (34D.F) Competitor Comparison

We are evaluating the key criteria listed to compare Diasorin (34D.F) against its competitors in the Diagnostics & Research industry.

Market Capitalization

0 / 58

Gross Profits

0 / 52

Total Revenue

0 / 57

EBITDA

0 / 56

Free Cashflow

0 / 56

Quick Ratio

0 / 57

Earnings per Share

0 / 55

Dividend yield

0 / 8

Total Cash

0 / 57

Performance 3 years

0 / 58

Performance 5 years

0 / 58

Performance 10 years

0 / 58

Linearity 3 years

0 / 58

Linearity 5 years

0 / 58

Linearity 10 years

0 / 58

Total Rank

0 / 58

Dividend Rank

0 / 58

Valuation Rank

0 / 58

Piotroski Rank

0 / 58

Muliplier Rank

0 / 58

Performance 10 years - 34D.F ranking 0 / 58

These are the competitors of Diasorin in the industry Diagnostics & Research ranked by performance 10 years
1. Heska HSKA
1.65K
2. Lantheus Holdings LNTH
1.39K
3. Medpace Holdings MEDP
1.1K
4. Natera NTRA
779.78
5. RadNet RDNT
625.58
6. DexCom DXCM
469.37
7. IDEXX Laboratories IDXX
422.93
8. Thermo Fisher Scientific TMO
344.17
9. Mettler-Toledo MTD
340.83
10. Danaher DHR
327.09
11. Agilent Technologies A
283.45
12. Twist Bioscience TWST
265.85
13. NeoGenomics NEO
255.25
14. Waters WAT
254.2
15. PerkinElmer PKI
247.07
16. Icon ICLR
242.51
17. IQVIA Holdings IQV
228.93
18. CareDx CDNA
197.36
19. Charles River Laboratories CRL
138.16
20. Laboratory Corp of America Holdings LH
135.48
21. Quest Diagnostics DGX
115.97
22. Syneos Health SYNH
113.83
23. Inotiv NOTV
91.48
24. Qiagen QGEN
86.09
25. Exact Sciences EXAS
85.85
26. Fulgent Genetics FLGT
85.67
27. Meridian Bioscience VIVO
60.69
28. Guardant Health GH
32.11
29. National Research NRC
29.83
30. Ortho Clinical Diagnostics Holdings OCDX
13.74
31. Anixa Biosciences ANIX
-19.67
32. Illumina ILMN
-24.06
33. Olink Holding OLK
-26.82
34. Bioventus BVS
-33.51
35. Neogen NEOG
-36.13
36. Sotera Health SHC
-51.93
37. Sera Prognostics SERA
-57.23
38. Global Cord Blood CO
-66.57
39. Myriad Genetics MYGN
-68.19
40. MaxCyte MXCT
-70.92
41. DarioHealth DRIO
-75.47
42. Exagen XGN
-76.25
43. Enzo Biochem ENZ
-77.8
44. Pacific Biosciences of California PACB
-79.08
45. Personalis PSNL
-79.28
46. Co-Diagnostics CODX
-83.5
47. MDxHealth MDXH
-83.87
48. Psychemedics PMD
-86.47
49. bioAffinity Technologies BIAF
-88.45
50. Biodesix BDSX
-91.54
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-95.27
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-98.9
56. Organovo Holdings ONVO
-99.26
57. Interpace Biosciences IDXG
-99.49
58. Precipio PRPO
-99.75
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.